In fact, NO availability was increased in the kidney and heart upon diabetes, while liver NO was decreased, despite elevated levels of the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA). This evidence concerns the gene NOS1 and diabetes mellitus.